Skip to main content

Table 2 Univariate and multivariate Cox analysis of relapse-free survival in patients with primary breast cancer

From: Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2

Factor

Univariate P

Multivariate P

Relative risk for relapse

95% CI

P-Akt

0.01

0.02

2.09

1.14–3.85

Node status

0.0003

0.09

1.33

0.95–1.85

ER status

0.03

0.17

0.67

0.38–1.19

ErbB-2 status

0.002

0.04

1.73

1.02–2.94

Grading

0.03

0.06

1.57

0.98–2.50

Tumour size

0.00005

0.02

1.51

1.07–2.13

  1. CI, confidence interval; ER, oestrogen receptor; P-Akt, phosphorylated Akt.